Enhanced Analysis with New Triple Quadrupole Mass Spectrometer

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletterPharmaceutical Technology\'s In the Lab eNewsletter-09-05-2018
Volume 13
Issue 9

The TSQ Fortis Triple Quadrupole Mass Spectrometer from Thermo Fisher Scientific offers fast, robust liquid chromatography-mass spectrometry (LC-MS/MS) analysis for clinical research laboratories.

The Thermo Scientific TSQ Fortis Triple Quadrupole Mass Spectrometer allows clinical research laboratory scientists who face challenges in developing reproducible and reliable methods for the quantitation of analytes in biological matrices to achieve higher productivity while meeting laboratory demands.

The mass spectrometer is suited for applications that demand speed, robustness, and sensitivity for the quantitation of compounds in biological matrices by users with varying levels of expertise.

Features include:

  • Active Ion Management Plus, which enables high precision for every molecule type in complex matrices

  • Selected reaction monitoring capability with ion transmission efficiency, which is designed for simultaneous, reliable quantitation of all components in a complex matrix for high instrument throughput

  • An ion optics design that allows for simple, tool-free maintenance

  • Matrix Separator Ion Guide for maximum robustness while minimizing ion loss

  • Simplified workflows that offer efficiency without compromising data quality from sample injection to report generation

  • Intuitive drag-and-drop method editor software for simple method development and operation through application-based templates.

The instrument’s platform is built on a foundation of shared hardware and software components and can be paired with a range of high-performance Thermo Scientific liquid chromatography systems. This pairing capability enables users to go from single-sample-based experiments to validation to routine high-volume screening and quantification, the company reports.

Source: Thermo Fisher Scientific

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content